Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vaginal misoprostol vs conventional oral regimen for cervical preparation in surgical abortion at 10–12 weeks
ChiCTR2500108652Phase 4Not yet recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of misoprostol in Induced Abortion (TOP) (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoint: Effective rate of cervical dilation. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
Induced Abortion (TOP)
Beyond the preview
Go deeper on ChiCTR2500108652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108652.